BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20541952)

  • 1. Alzheimer's disease: brain expression of a metabolic disorder?
    Merlo S; Spampinato S; Canonico PL; Copani A; Sortino MA
    Trends Endocrinol Metab; 2010 Sep; 21(9):537-44. PubMed ID: 20541952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acids, lipid metabolism and Alzheimer pathology.
    Hooijmans CR; Kiliaan AJ
    Eur J Pharmacol; 2008 May; 585(1):176-96. PubMed ID: 18378224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease.
    Poirier J
    Neurobiol Aging; 2005 Mar; 26(3):355-61. PubMed ID: 15639314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol and pathological processes in Alzheimer's disease.
    Yanagisawa K
    J Neurosci Res; 2002 Nov; 70(3):361-6. PubMed ID: 12391598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism.
    Wellington CL
    Clin Genet; 2004 Jul; 66(1):1-16. PubMed ID: 15200500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E in the brain and its role in Alzheimer's disease.
    Poirier J
    J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF lipoproteins and Alzheimer's disease.
    Neely MD; Montine TJ
    J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.
    Praticò D
    Trends Pharmacol Sci; 2008 Dec; 29(12):609-15. PubMed ID: 18838179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High carbohydrate diets and Alzheimer's disease.
    Henderson ST
    Med Hypotheses; 2004; 62(5):689-700. PubMed ID: 15082091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain aging and Alzheimer's disease; use it or lose it.
    Swaab DF; Dubelaar EJ; Hofman MA; Scherder EJ; van Someren EJ; Verwer RW
    Prog Brain Res; 2002; 138():343-73. PubMed ID: 12432778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
    Blass JP; Gibson GE
    Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.
    Smith IF; Hitt B; Green KN; Oddo S; LaFerla FM
    J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-modifying strategies for Alzheimer's disease.
    Solomon A; Kivipelto M
    Expert Rev Neurother; 2009 May; 9(5):695-709. PubMed ID: 19402779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
    Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.
    Takechi R; Galloway S; Pallebage-Gamarallage MM; Lam V; Mamo JC
    Prog Lipid Res; 2010 Apr; 49(2):159-70. PubMed ID: 19896503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.